Cargando…

Roles of the immune system in cancer: from tumor initiation to metastatic progression

The presence of inflammatory immune cells in human tumors raises a fundamental question in oncology: How do cancer cells avoid the destruction by immune attack? In principle, tumor development can be controlled by cytotoxic innate and adaptive immune cells; however, as the tumor develops from neopla...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez, Hugo, Hagerling, Catharina, Werb, Zena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169832/
https://www.ncbi.nlm.nih.gov/pubmed/30275043
http://dx.doi.org/10.1101/gad.314617.118
_version_ 1783360564962000896
author Gonzalez, Hugo
Hagerling, Catharina
Werb, Zena
author_facet Gonzalez, Hugo
Hagerling, Catharina
Werb, Zena
author_sort Gonzalez, Hugo
collection PubMed
description The presence of inflammatory immune cells in human tumors raises a fundamental question in oncology: How do cancer cells avoid the destruction by immune attack? In principle, tumor development can be controlled by cytotoxic innate and adaptive immune cells; however, as the tumor develops from neoplastic tissue to clinically detectable tumors, cancer cells evolve different mechanisms that mimic peripheral immune tolerance in order to avoid tumoricidal attack. Here, we provide an update of recent accomplishments, unifying concepts, and future challenges to study tumor-associated immune cells, with an emphasis on metastatic carcinomas.
format Online
Article
Text
id pubmed-6169832
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Cold Spring Harbor Laboratory Press
record_format MEDLINE/PubMed
spelling pubmed-61698322019-04-01 Roles of the immune system in cancer: from tumor initiation to metastatic progression Gonzalez, Hugo Hagerling, Catharina Werb, Zena Genes Dev Review The presence of inflammatory immune cells in human tumors raises a fundamental question in oncology: How do cancer cells avoid the destruction by immune attack? In principle, tumor development can be controlled by cytotoxic innate and adaptive immune cells; however, as the tumor develops from neoplastic tissue to clinically detectable tumors, cancer cells evolve different mechanisms that mimic peripheral immune tolerance in order to avoid tumoricidal attack. Here, we provide an update of recent accomplishments, unifying concepts, and future challenges to study tumor-associated immune cells, with an emphasis on metastatic carcinomas. Cold Spring Harbor Laboratory Press 2018-10-01 /pmc/articles/PMC6169832/ /pubmed/30275043 http://dx.doi.org/10.1101/gad.314617.118 Text en © 2018 Gonzalez et al.; Published by Cold Spring Harbor Laboratory Press http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Review
Gonzalez, Hugo
Hagerling, Catharina
Werb, Zena
Roles of the immune system in cancer: from tumor initiation to metastatic progression
title Roles of the immune system in cancer: from tumor initiation to metastatic progression
title_full Roles of the immune system in cancer: from tumor initiation to metastatic progression
title_fullStr Roles of the immune system in cancer: from tumor initiation to metastatic progression
title_full_unstemmed Roles of the immune system in cancer: from tumor initiation to metastatic progression
title_short Roles of the immune system in cancer: from tumor initiation to metastatic progression
title_sort roles of the immune system in cancer: from tumor initiation to metastatic progression
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169832/
https://www.ncbi.nlm.nih.gov/pubmed/30275043
http://dx.doi.org/10.1101/gad.314617.118
work_keys_str_mv AT gonzalezhugo rolesoftheimmunesystemincancerfromtumorinitiationtometastaticprogression
AT hagerlingcatharina rolesoftheimmunesystemincancerfromtumorinitiationtometastaticprogression
AT werbzena rolesoftheimmunesystemincancerfromtumorinitiationtometastaticprogression